World's Best Scientists 2026 revealed!
Raymond F. Schinazi

Raymond F. Schinazi

D-Index & Metrics

Biology and Biochemistry

D-Index
102
Citations
39695
World Ranking
1360
National Ranking
787

Raymond F. Schinazi publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Raymond F. Schinazi sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 713 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Raymond F. Schinazi D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond F. Schinazi sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 102 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Raymond F. Schinazi is affiliated with Emory University in the United States. Their research predominantly covers fields related to medicine, with a particular focus on infectious diseases, epidemiology, molecular biology, virology, and hepatology. The body of work includes a significant number of publications documenting scientific advancements in these areas.

The scientist's research topics include:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Hepatitis B Virus Studies
  • SARS-CoV-2 detection and testing

Frequent publication venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Biological Chemistry
  • Viruses
  • Molecules
  • UNC Libraries

Among recent papers authored or co-authored by Schinazi are:

  • "COVID-19: Discovery, diagnostics and drug development," 2020, Journal of Hepatology
  • "Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template," 2021, Journal of Biological Chemistry
  • "β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells," 2021, The Journal of Infectious Diseases
  • "Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques," 2020, Cell
  • "Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020," 2020, Emerging Infectious Diseases

Raymond F. Schinazi has collaborated extensively with several co-authors throughout their career. Some of the most frequent collaborators include:

  • Leda Bassit
  • Franck Amblard
  • Baek Kim
  • Sijia Tao
  • Keivan Zandi

Their work spans infectious disease mechanisms, antiviral drug development, and clinical research related to pandemics and viral infections. This range of topics reflects interdisciplinary expertise intersecting virus biology, therapeutic innovation, and epidemiological surveillance within the scope of global health challenges.

Best Publications

  • A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

    Lieven Stuyver;Sija De Gendt;Caroline Van Geyt;Fabien Zoulim

  • Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

    Shin-Lian Doong;Ching-Hwa Tsai;Raymond F. Schinazi;Dennis C. Liotta

  • Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs

    Ugo Pradere;Ethel C. Garnier-Amblard;Steven J. Coats;Franck Amblard

  • Zika Virus Infects Human Placental Macrophages

    Kendra M. Quicke;Kendra M. Quicke;James R. Bowen;James R. Bowen;Erica L. Johnson;Circe E. McDonald;Circe E. McDonald

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Polyoxometalate HIV-1 Protease Inhibitors. A New Mode of Protease Inhibition

    Deborah A. Judd;James H. Nettles;Neysa Nevins;James P. Snyder

  • Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.

    Lin Tai-Shun;Raymond F. Schinazi;William H. Prusoff

  • In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora

    Yuh-Meei Lin;Herbert Anderson;Michael T. Flavin;Yeah-Huei S. Pai

  • Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.

    C.N. Chang;S.L. Doong;J.H. Zhou;J.W. Beach

  • Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

    Mirjam B. Zeisel;Julie Lucifora;William S. Mason;Camille Sureau

  • Line probe assay for rapid detection of drug-selected mutations in the human immunodeficiency virus type 1 reverse transcriptase gene.

    L Stuyver;A Wyseur;A Rombout;J Louwagie

  • HCV direct‐acting antiviral agents: the best interferon‐free combinations

    Raymond Schinazi;Philippe Halfon;Patrick Marcellin;Tarik Asselah

  • Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV)

    J. Warren Beach;Lak S. Jeong;Antonio J. Alves;Douglas Pohl

  • β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.

    Shuntai Zhou;Collin S Hill;Sanjay Sarkar;Longping V Tse

  • Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease.

    Edward M. Kennedy;Leda C. Bassit;Henrik Mueller;Anand V.R. Kornepati

  • Ribonucleoside Analogue That Blocks Replication of Bovine Viral Diarrhea and Hepatitis C Viruses in Culture

    Lieven J. Stuyver;Tony Whitaker;Tamara R. McBrayer;Brenda I. Hernandez-Santiago

  • In situ complexation directs the stereochemistry of N-glycosylation in the synthesis of oxathiolanyl and dioxolanyl nucleoside analogues

    Woo Baeg Choi;Lawrence J. Wilson;Suresh Yeola;Dennis C. Liotta

  • Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.

    L. S. Jeong;R. F. Schinazi;J. W. Beach;H. O. Kim

  • Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

    Chung K. Chu;Raymond F. Schinazi;Moon K. Ahn;Giliyar V. Ullas

  • New Manzamine Alkaloids with Activity against Infectious and Tropical Parasitic Diseases from an Indonesian Sponge

    Karumanchi V. Rao;Bernardo D. Santarsiero;Andrew D. Mesecar;Raymond F Schinazi

Frequent Co-Authors

Chung K. Chu
Chung K. Chu University of Georgia
Baek Kim
Baek Kim Emory University
Yung-Chi Cheng
Yung-Chi Cheng Yale University
Dong-Hyun Kim
Dong-Hyun Kim Kyung Hee University
Mark T. Hamann
Mark T. Hamann Medical University of South Carolina
Charles M. Rice
Charles M. Rice Rockefeller University
Steven P. Nolan
Steven P. Nolan Ghent University
Jeffrey S. Glenn
Jeffrey S. Glenn Stanford University
Kyong-Mi Chang
Kyong-Mi Chang University of Pennsylvania
Wenhui Li
Wenhui Li Tsinghua University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in Biology and Biochemistry opens a range of online degree and certificate options that can boost your career potential. Many students pair these studies with fields focusing on human health, exercise, and patient care. For example, you might consider an exercise science online degree if you're interested in the science behind fitness and performance, or pursue one of the best online kinesiology degree programs for a broader understanding of body movement and mechanics.

For those with a background in biochemistry or biology looking toward healthcare, quick pathway options like the shortest pmhnp certificate program can prepare you for advanced roles in mental health nursing. Similarly, online fnp programs are available for those aiming to become Family Nurse Practitioners, often enabling fast completion for those who already have a graduate degree. These pathways let you leverage your science background while expanding your career opportunities in both clinical and research settings.

Best Scientists Citing Raymond F. Schinazi

Trending Scientists

Recently Published Articles